Company profile: PBM Labs
1.1 - Company Overview
Company description
- Provider of physician-owned, independent pathology laboratory services serving North Texas for more than 50 years, delivering technical, professional, consultative, and managerial pathology support. Offerings include anatomic pathology (histopathology, cytology, immunohistochemistry, forensic), renal diagnostics (native/transplant biopsies, 24-hour microscopy turnaround), hematopathology, flow cytometry, autopsy, and consultative services after-hours, weekends, and holidays.
Products and services
- Anatomic Pathology Services: Multi-modality service delivering histopathology, cytology, immunohistochemistry, and forensic pathology for hospitals, surgery centers, and physician offices, supporting comprehensive tissue, cell, and disease evaluation
- Consultative Services: Board-certified pathologists deliver consultative expertise on all specimen types, available after-hours, weekends, and holidays, ensuring continuous access to pathology consultation
- Flow Cytometry: Cytometry-based immunophenotypic analysis by flow cytometry on blood, bone marrow, body fluids, and tissues, including fine needle aspiration biopsy material
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PBM Labs
DynaLIFE
HQ: Canada
Website
- Description: Provider of high quality laboratory services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DynaLIFE company profile →
CPL
HQ: United States
Website
- Description: Provider of comprehensive clinical and anatomic pathology services, including expansive esoteric testing, molecular infectious disease testing, FNA/cytology/Pap tests, and specialized women's health testing. Serving the medical community for over sixty years with over 1850 employees, a 100,000 square foot main laboratory, remote operations across the Southwest, and a pathology-involved approach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CPL company profile →
Alinea
HQ: United States
Website
- Description: Provider of medical imaging services, including x-ray, CT scan, ultrasound, DEXA, mammogram, and MRI scan.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alinea company profile →
Solis Mammography
HQ: United States
Website
- Description: Provider of women's breast imaging and care services, including 3D and screening mammography, diagnostic mammograms and imaging, breast ultrasound and biopsy, bone density screenings, and a Breast Care Coordination program. Offers Mammo+Plus, an AI-based tool that calculates one-year breast cancer risk using mammogram images, age, and breast density.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Solis Mammography company profile →
BioReference
HQ: United States
Website
- Description: Provider of testing and related services as the third largest full-service clinical diagnostic laboratory in the U.S., serving physician offices, clinics, hospitals, long-term care facilities, employers, governmental units, and correctional institutions. Offers comprehensive tests in molecular diagnostics, anatomical pathology, oncology, urology, and women's health; HIPAA-compliant connectivity, patient portal, cost estimator, in-network billing, and specialty lab solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioReference company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PBM Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PBM Labs
2.2 - Growth funds investing in similar companies to PBM Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PBM Labs
4.2 - Public trading comparable groups for PBM Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →